Bellerophon Therapeutics, Inc.
BLPH
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -9.25M | -12.40M | -11.37M | -19.83M | -19.09M |
| Total Depreciation and Amortization | 6.00K | 27.00K | 45.00K | 65.00K | 82.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 439.00K | 775.00K | 857.00K | 785.00K | 724.00K |
| Change in Net Operating Assets | -3.53M | 582.00K | 698.00K | 1.21M | 885.00K |
| Cash from Operations | -12.34M | -11.02M | -9.77M | -17.77M | -17.40M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 140.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 140.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.01M | 5.01M | 1.44M | -- | -- |
| Repurchase of Common Stock | -42.00K | -42.00K | -40.00K | -40.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 3.55M | -- | -- |
| Cash from Financing | 4.97M | 4.97M | 4.94M | -40.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.23M | -6.05M | -4.83M | -17.81M | -17.40M |
